Bellevue Group AG - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 68 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2023$23,349,858
-43.2%
8,135,8390.0%0.38%
-35.8%
Q2 2023$41,085,987
+302.9%
8,135,839
+50.8%
0.59%
+295.9%
Q1 2023$10,198,136
+4.9%
5,395,839
-0.1%
0.15%
+14.7%
Q4 2022$9,721,510
+21.9%
5,400,839
+14.5%
0.13%
+13.2%
Q3 2022$7,972,000
-31.3%
4,717,1130.0%0.11%
-30.5%
Q2 2022$11,605,000
+27.2%
4,717,113
+43.2%
0.16%
+54.7%
Q1 2022$9,122,000
-50.6%
3,293,000
-4.9%
0.11%
-44.2%
Q4 2021$18,458,000
-37.0%
3,463,0000.0%0.19%
-36.0%
Q3 2021$29,297,000
-30.6%
3,463,0000.0%0.30%
-27.9%
Q2 2021$42,214,000
-22.4%
3,463,000
+54.4%
0.41%
-28.5%
Q1 2021$54,415,000
+21.0%
2,243,000
+59.9%
0.58%
+11.8%
Q4 2020$44,967,000
+6.0%
1,403,0000.0%0.52%
-12.1%
Q3 2020$42,413,000
-28.3%
1,403,0000.0%0.59%
-30.0%
Q2 2020$59,150,000
+78.2%
1,403,000
+5.5%
0.84%
+30.0%
Q1 2020$33,184,0001,330,0000.64%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q3 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$8,487,0000.44%
Hawkeye Capital Management, LLC 243,009$598,0000.33%
Boxer Capital, LLC 2,014,858$4,957,0000.31%
Newtyn Management, LLC 520,000$1,279,0000.24%
Artal Group S.A. 1,646,517$4,050,0000.22%
DAFNA Capital Management LLC 313,600$771,0000.21%
RA Capital Management 2,589,904$6,371,0000.17%
Bellevue Group AG 4,717,113$11,605,0000.16%
MPM BioImpact LLC 239,888$590,0000.16%
K2 PRINCIPAL FUND, L.P. 507,652$1,249,0000.14%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders